blue cross blue shield not covering glp 1 Drops Coverage of GLP-1 Obesity Drugs MCT2D | 2023 Updates to
Description
Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
Increased sweating affects some semaglutide users during treatment
FDA updates rules on compounded GLP-1 drugs, impacting patients and providers
GLP-1 Medications: The Good, the Bad, and the Clinically Honest A Clinician's Guide to Ozempic, Wegovy, and the Questions Nobody Is Asking By Iris Epstein, RDN, CEDS, CAI | Founder, Nutrition Improvement Center for Restrictive Disorders (NICRD) The #1 Health Trend of 2026 and What Nobody Is Saying
Formulated for systemic health, it works to enhance your body's natural processes
PlexusDx connects you with licensed prescribers who offer compounded semaglutide injections starting at $149/month without insurance requirements
